Lota Zoth
Director/Board Member chez 89BIO, INC.
Fortune : 25 M $ au 31/03/2024
Profil
Lota S.
Zoth is currently an Independent Director at 89bio, Inc., Lumos Pharma, Inc., enGene Holdings, Inc., and Inovio Pharmaceuticals, Inc. Previously, Ms. Zoth served as the Chairman of Zymeworks BC, Inc. from 2019 to 2022.
Ms. Zoth was also the Chairman of Orexigen Therapeutics, Inc. from 2018 to 2019.
Additionally, Ms. Zoth held positions as an Independent Director at NewLink Genetics Corp., a Director at Aeras Global TB Vaccine Foundation from 2011 to 2018, a Non-Executive Director at Hyperion Therapeutics, Inc. in 2015, a Director at Ikaria, Inc. from 2007 to 2014, an Independent Director at Spark Therapeutics, Inc. from 2016 to 2019, a Senior Independent Non-Executive Director at Niox Group Plc from 2015 to 2019, and the Lead Independent Director at Zymeworks, Inc. from 2016 to 2023.
Ms. Zoth also held positions at PepsiCo, Inc., PSINet, Inc., Marriott International, Inc., Ernst & Young LLP (Missouri), Sodexho Marriott Services, Inc., and Medimmune, Inc. Ms. Zoth obtained an undergraduate degree from Texas Tech University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
89BIO INC
2,29% | 01/02/2024 | 2 140 000 ( 2,29% ) | 25 M $ | 31/03/2024 |
| 16/11/2023 | 4 393 ( 0,02% ) | 60 975 $ | 31/03/2024 | |
LUMOS PHARMA, INC.
0,03% | 10/05/2023 | 2 187 ( 0,03% ) | 6 167 $ | 31/03/2024 |
ENGENE HOLDINGS INC.
-.--% | 21/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
ZYMEWORKS INC.
-.--% | 11/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Lota Zoth
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2018 |
| LUMOS PHARMA, INC. | Director/Board Member | 01/11/2012 |
| 89BIO, INC. | Director/Board Member | 01/06/2020 |
| ENGENE HOLDINGS INC. | Director/Board Member | 18/12/2023 |
Anciens postes connus de Lota Zoth
| Sociétés | Poste | Fin |
|---|---|---|
| ZYMEWORKS INC. | Chairman | 01/01/2022 |
| SPARK THERAPEUTICS, INC. | Director/Board Member | 17/12/2019 |
| OREXIGEN THERAPEUTICS, INC. | Chairman | 01/05/2019 |
| NIOX GROUP PLC | Director/Board Member | 01/01/2019 |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Director/Board Member | 01/01/2018 |
Formation de Lota Zoth
| Texas Tech University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| PEPSICO, INC. | Consumer Non-Durables |
| MARRIOTT INTERNATIONAL, INC. | Consumer Services |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| NIOX GROUP PLC | Health Services |
| 89BIO, INC. | Health Technology |
| LUMOS PHARMA, INC. | Health Technology |
| ZYMEWORKS INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
| PSINet, Inc. | Communications |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Commercial Services |
Sodexho Marriott Services, Inc.
 Sodexho Marriott Services, Inc. Personnel ServicesCommercial Services Part of Sodexo SA, Sodexho Marriott Services, Inc. offers outsourcing solutions to the corporate, health care and education markets. The private company is based in Jersey City, NJ. The CEO of the company is Michel Landel. | Commercial Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
| Medimmune, Inc. | Health Technology |
| enGene Holdings, Inc. |
